Literature DB >> 2850288

Immunocytochemical investigation of hepatitis B virus-associated antigens in cases of liver cirrhosis and HBsAg antigenemia and their relationship to development of hepatocellular carcinoma.

M Iwai1, M Kashiwadani, T Okuno, T Takino, Y Ibata.   

Abstract

Using light and ultrastructural immunoperoxidase techniques, we examined the distribution of hepatitis B virus (HBV)-associated antigens and the subcellular localization of hepatitis B surface antigen (HBsAg) in liver biopsies of HBsAg-positive patients with cirrhosis. The localization patterns of HBsAg in hepatocytes were membranous, cytoplasmic, festoon and inclusion body types. Cytoplasmic and festoon types were seen more often than the membranous type in pseudolobules, and hepatitis B core antigen (HBcAg)-positive cells with cytoplasmic type were distributed in the periphery of pseudolobules with active inflammation. Immunoelectron microscopy in the cytoplasmic or festoon type of HBsAg showed immunoreaction in the cisternae and on virus-like particles in the cisternae in patients with hepatitis B e antigen (HBeAg) antigenemia. Simultaneous staining of HBsAg and HBcAg revealed that hepatocytes with cytoplasmic or festoon type of HBsAg contained HBcAg-immunoreactivity. The inclusion body type of HBsAg was characteristic of liver cirrhosis with hepatocellular carcinoma (HCC); the subcellular localization of HBsAg was seen in clusters of the endoplasmic reticulum around the nucleus, and HBsAg-immunoreactivity was observed on many virus-like particles in most of the cisternae in those with HBeAg antigenemia. These findings suggest that the synthesis of HBsAg is active in patients with liver cirrhosis and that the formation of HBV is also active in those with HBeAg antigenemia and that HBV may be retained more in cirrhotic livers with hepatocellular carcinoma after proliferation than in those without it.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850288     DOI: 10.1007/bf01745607

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  14 in total

Review 1.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors:  W Szmuness
Journal:  Prog Med Virol       Date:  1978

2.  Immunohistologic demonstration of hepatitis B viral antigens in liver with reference to its significance in liver injury.

Authors:  S N Huang; A R Neurath
Journal:  Lab Invest       Date:  1979-01       Impact factor: 5.662

3.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

Review 4.  Hepatocellular carcinoma and type B hepatitis.

Authors:  S J Hadziyannis
Journal:  Clin Gastroenterol       Date:  1980-01

5.  Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis.

Authors:  C M Chu; Y F Liaw
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

6.  Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients.

Authors:  M B Ray; V J Desmet; A F Bradburne; J Desmyter; J Fevery; J De Groote
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

7.  Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma.

Authors:  C Brechot; C Pourcel; A Louise; B Rain; P Tiollais
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

8.  Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.

Authors:  S Hirohashi; Y Shimosato; Y Ino; K Kishi
Journal:  J Natl Cancer Inst       Date:  1982-09       Impact factor: 13.506

9.  Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

10.  Hepatitis B core particles with endogenous DNA polymerase activity from chimpanzee liver.

Authors:  H Onda; S Matsuda; Y Oka
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.